top of page

The
Promise of
Interleukin-2
Therapy.
4 - 7 Sept. 2024
For autoimmune and inflammatory diseases, allergy, transplantation and cancer
Centre international de Conférences Sorbonne Université
4 place Jussieu
75005 - Paris, France
*To submit before June 15th, 2024
Confirmed Speakers
(by alphabetical order)
Christoph Binder, Pierre Ellul, Ron Germain, Jonathan Kipnis, David Klatzmann, Zhanguo Li, Adrian Liston, Ziad Mallat, Diane Mathis, Thomas Malek, Alexander Marson, Marc Martinez Llordella, Suman Mitra, Janie Robert, Aleksander Rudensky, Jamie Spangler, Shimon Sakaguchi, Qizhi Tang, Lucy Walker, Benjamin Youngblood, Jonathan Zalevsky
Confirmed Speakers
Schedule Fri. 6th
Friday 6th
9.00 am
Session V
Immunotherapy of brain disorders
Chair : David Klatzmann
1. IL-2 in ALS - Leigh N. 30' (pending)
2. Gene delivery of IL2 and IL2 muteins as a therapeutic – Adrian Liston 30’
Talks from abstract
11.00-11.30 am
Coffee Break
11.30 am
Session VI
IL-2 and Treg cell therapies (1)
Chair : Qizhi Tang
1. Translating epigenetic mechanisms of T cell exhaustion into durable immunotherapy - Benjamin Youngblood
2. Engineered CAR-Treg therapies to enhance immune regulation in transplantation and autoimmunity - Marc Martinez Llordella
Talks from abstract
1.00 pm
Lunch & posters
2.00 pm
4.00 pm
Session VII
IL-2 and Treg cell therapies (2)
Chair : Christophe Benoist
3. Enhancing Treg cell therapy with autocrine IL-2 - Qizhi Tang
4. Targeting eTregs to inflammatory sites – Janie Robert
Talks from abstract
3.30 - 4.00 pm
Coffee Break
Session VIII
Novel IL-2s, vectorisation and combination therapies
Chair : Lucy Walker
1. Low-dose IL-2/CD25 remodels inflamed tissues to limit autoimmunity - Thomas Malek
2. Engineered cytokine/antibody fusion proteins for Treg-targeted immunotherapy - Jamie Spangler
3. Oxidation Specific epitopes for targeting IL-2 to inflammatory sites - Christoph Binder
Talks from abstract
6.00 pm
Drinks & posters
7.00 pm
End of the day
bottom of page